Aura Biosciences Strengthens and Expands Leadership Team wit

J. Jill Hopkins, M.D., Appointed as Chief Medical Officer and President of Research & DevelopmentMark Plavsic, Ph.D., Appointed as Chief Technology OfficerBOSTON--(BUSINESS WIRE)--Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC)...

Related Keywords

Ottawa , Ontario , Canada , United Kingdom , Moorfields , Ballymena , Toronto , United States , Belgrade , Serbia General , , Boston , Massachusetts , American , Los Pinos , J Jill Hopkins , Mark Plavsic , Jill Hopkins , Sanofi Genzyme , Royal College Of Surgeons Canada , Aura Biosciences Inc , University Of Toronto , Mcmaster University , Technology Development Manufacturing , Technology Officer , Twitter , University Of Southern California , Research Development , Exploratory Development At Novartis , Vitreous Associates Medical Group , Novartis , Nasdaq , American College Of Veterinary Microbiologists , Astrazeneca , Regulatory Affairs Certification , University Of Belgrade , Linkedin , Global Head Ophthalmology Personalized Health Care , Company As Senior Clinical Advisor , Exchange Commission , Chief Medical Officer , Chief Technology , Aura Biosciences , Cadmus Rich , Senior Clinical , Elisabet De Los Pinos , Chief Executive Officer , Senior Vice President , Global Head , Exploratory Development , Gyroscope Therapeutics , Global Head Ophthalmology Personalized Health , Before Roche Genentech , Southern California , Retina Vitreous Associates Medical , Retinal Disease , Moorfields Eye Hospital , London United Kingdom , Visual Electrophysiology , American Board , Royal College , Chief Technology Officer , Fate Therapeutics , Chief Technical Officer , Technical Operations , Technology Development , Q One Biotech , American College , Veterinary Microbiologists , Private Securities Litigation Reform Act , Annual Report ,